ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Retail Trade

Sugi Holdings Co., Ltd.

Business Summary

Sugi Holdings Co., Ltd. engages in the management of its group companies which are in the medical business. It sells pharmaceuticals, health food, cosmetic products, and daily necessities. The company was founded in December 1976 and is headquartered in Obu, Japan.

Financial Highlights

Feb 2020 JPYUSD
Revenue541,964M4,971.69M
Gross Profit162,182M1,487.77M
Operating income29,762M273.02M
Income before tax29,926M274.52M
Net income20,782M190.64M
EBITDA38,174M350.18M
Diluted EPS336.203.08
Dividends Per Share800.73
Total Assets314,905M2,919.43M
Total liabilities132,153M1,225.17M
Total equity182,750M1,694.24M
Operating cash flow45,353M416.04M
Currency in JPYCurrency in USD

Historical Data

 Feb 2016Feb 2017Feb 2018Feb 2019Feb 2020
Revenue 414,885M 430,795M 457,047M 488,464M 541,964M
Gross Profit 115,711M 120,009M 131,566M 142,300M 162,182M
Operating income 23,112M 22,833M 24,762M 25,817M 29,762M
Income before tax 22,826M 22,521M 24,559M 26,053M 29,926M
Net income 14,605M 14,947M 16,411M 17,940M 20,782M
EBITDA 28,379M 28,432M 31,217M 33,206M 38,174M
Diluted EPS 230.67 236.08 259.19 287.73 336.20
Dividends Per Share 45 50 60 70 80
Total Assets 218,762M 230,664M 254,934M 266,529M 314,905M
Total liabilities 81,980M 81,880M 92,886M 99,964M 132,153M
Total equity 136,782M 148,782M 162,046M 166,563M 182,750M
Operating cash flow 13,247M 16,912M 27,562M 22,894M 45,353M
 Feb 2016Feb 2017Feb 2018Feb 2019Feb 2020
Revenue 3,436.55M 3,978.91M 4,102.53M 4,421.30M 4,971.69M
Gross Profit 958.45M 1,108.42M 1,180.96M 1,288.02M 1,487.77M
Operating income 191.44M 210.89M 222.26M 233.68M 273.02M
Income before tax 189.07M 208.00M 220.44M 235.81M 274.52M
Net income 120.97M 138.05M 147.30M 162.38M 190.64M
EBITDA 235.06M 262.60M 280.20M 300.56M 350.18M
Diluted EPS 1.91 2.18 2.32 2.60 3.08
Dividends Per Share 0.37 0.46 0.53 0.63 0.73
Total Assets 1,938.09M 2,061.61M 2,389.14M 2,394.25M 2,919.43M
Total liabilities 726.29M 731.82M 870.49M 897.98M 1,225.17M
Total equity 1,211.80M 1,329.77M 1,518.63M 1,496.25M 1,694.24M
Operating cash flow 109.72M 156.20M 247.40M 207.22M 416.04M

Valuation Measures

Feb 2020
PER15.19
ROA7.14%
ROE11.89%
Operating margin5.49%
Profit margin3.83%

Key executives

  • President & Representative Director: Eiichi Sakakibara
  • Representative Director & Vice President: Katsunori Sugiura
  • Manager-Business Planning Office: Makoto Kasai

Shareholders

  • SUGIURA FAMILY (32.5%)
  • Baillie Gifford & Co. (6.1%)
  • Select Equity Group LP (4.9%)
  • SUGIURA KATSUNORI (2.9%)
  • SUGIURA SHINYA (2.9%)
  • Sugi Holdings Co., Ltd. (2.3%)
  • TSURUHA Holdings, Inc. (2.0%)
  • Nomura Asset Management Co., Ltd. (1.8%)
  • Newton Investment Management Ltd. (1.6%)
  • Sands Capital Management LLC (1.6%)

Contact Details

Related Companies

  • Sugi Medical Co. Ltd.
  • Sugi Pharmacy Co., Ltd.

Competitors

  • cocokara fine Inc.
Last Updated on 7 Aug, 2020

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media